BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng DJ, Zhou J, Zhu BD, Ji JF, Harper JC, Powell SM. Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. World J Gastroenterol 2003; 9(1): 26-29 [PMID: 12508345 DOI: 10.3748/wjg.v9.i1.26] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Li S, Zheng Y, Tian T, Wang M, Liu X, Liu K, Zhai Y, Dai C, Deng Y, Li S, Dai Z, Lu J. Pooling-analysis on hMLH1 polymorphisms and cancer risk: evidence based on 31,484 cancer cases and 45,494 cancer-free controls. Oncotarget 2017;8:93063-78. [PMID: 29190978 DOI: 10.18632/oncotarget.21810] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Han Y, Shi K, Zhou SJ, Yu DP, Liu ZD. The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review. Onco Targets Ther 2016;9:5081-90. [PMID: 27574449 DOI: 10.2147/OTT.S106345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
3 Hegde M, Ferber M, Mao R, Samowitz W, Ganguly A; Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee. ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Genet Med. 2014;16:101-116. [PMID: 24310308 DOI: 10.1038/gim.2013.166] [Cited by in Crossref: 110] [Cited by in F6Publishing: 124] [Article Influence: 11.0] [Reference Citation Analysis]
4 He Y, Xu X, Chen H, Wang J, Xiong W, Xu Y, Liu J. The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis. Gene 2013;523:199-204. [PMID: 23587910 DOI: 10.1016/j.gene.2013.03.138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Pan XM, Yang WZ, Xu GH, Bai P, Qin HJ, Zhang LS, Zhai XD, Tang M, Deng W, Zhang L, Gao LB. The association between MLH1 -93 G>A polymorphism of DNA mismatch repair and cancer susceptibility: a meta-analysis. Mutagenesis 2011;26:667-73. [PMID: 21745804 DOI: 10.1093/mutage/ger032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
6 Deng D, Liu Z, Du Y. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers. Adv Genet 2010;71:125-76. [PMID: 20933128 DOI: 10.1016/B978-0-12-380864-6.00005-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
7 Fan H, Zhao Z, Quan Y, Xu J, Zhang J, Xie W. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721. Eur J Gastroenterol Hepatol 2007;19:952-61. [PMID: 18049164 DOI: 10.1097/MEG.0b013e3282c3a89e] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
8 Shen J, Zhang JZ, Ke Y, Deng D. Formation of A2143G mutation of 23S rRNA in progression of clarithromycin resistance in Helicobacter pylori 26695. Microb Drug Resist. 2005;11:100-106. [PMID: 15910222 DOI: 10.1089/mdr.2005.11.100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
9 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 751-753 [DOI: 10.11569/wcjd.v12.i3.751] [Reference Citation Analysis]
10 Bjørheim J, Abrahamsen TW, Kristensen AT, Gaudernack G, Ekstrøm PO. Approach to analysis of single nucleotide polymorphisms by automated constant denaturant capillary electrophoresis. Mutat Res 2003;526:75-83. [PMID: 12714185 DOI: 10.1016/s0027-5107(03)00033-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]